Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation

Status:
Completed

Trial end date:
2006-03-01

Target enrollment:

Participant gender:

To establish the optimal dose of lasofoxifene that is fully effective in increasing the BMD in postmenopausal Asian women.

Phase 2

Ligand Pharmaceuticals